Responder Analyses Show Treatment with Aficamten Demonstrated Improvements on Multiple Assessments of Clinical Significance ...

NIH grant fuels research to find improved treatments for heart failure, aiming to advance care and enhance outcomes for ...

Phoenix researcher was recently awarded a $1.9 million National Institutes of Health grant to study the molecular mechanisms of how dilated cardiomyopathy progresses to heart failure, which could ...

A new analysis from SEQUOIA-HCM showed that treatment with aficamten was associated with beneficial changes in five indices reflecting structural, electrophysiologic and biomarker changes in patients ...

This study used dilated cardiomyopathy data from the OpenGWAS ... Overall, the findings pave the way for metabolite-centered precision prevention and treatment strategies. Finally, this work ...

Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...